As of May 2023 Bristol-Myers Squibb has a market cap of $133.84 Billion. This makes Bristol-Myers Squibb the world's 85th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $133.84 B | -12.51% |
2022 | $152.97 B | 10.54% |
2021 | $138.39 B | -1.27% |
2020 | $140.17 B | -1.99% |
2019 | $143.01 B | 69.42% |
2018 | $84.41 B | -15.83% |
2017 | $100.29 B | 2.69% |
2016 | $97.66 B | -14.52% |
2015 | $114.26 B | 17.1% |
2014 | $97.57 B | 11.88% |
2013 | $87.21 B | 64.19% |
2012 | $53.12 B | -11.04% |
2011 | $59.71 B | 32.73% |
2010 | $44.98 B | 4.26% |
2009 | $43.15 B | -6.24% |
2008 | $46.02 B | -12.08% |
2007 | $52.35 B | 1.38% |
2006 | $51.63 B | 14.83% |
2005 | $44.97 B | -9.84% |
2004 | $49.88 B | -10.1% |
2003 | $55.48 B | 22.68% |
2002 | $45.22 B | -54.81% |
2001 | $100.07 B |
On May 30th, 2023 the market cap of Bristol-Myers Squibb was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $401.16 B | 199.72% | ๐บ๐ธ USA |
![]() Novartis NVS | $204.64 B | 52.90% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $208.93 B | 56.10% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $240.71 B | 79.85% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $405.56 B | 203.01% | ๐บ๐ธ USA |
![]() Amgen AMGN | $116.76 B | -12.76% | ๐บ๐ธ USA |
![]() Sanofi SNY | $127.90 B | -4.44% | ๐ซ๐ท France |
![]() Biogen BIIB | $43.23 B | -67.70% | ๐บ๐ธ USA |
![]() Merck MRK | $277.01 B | 106.96% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $221.54 B | 65.53% | ๐ฌ๐ง UK |